Oncology

Addressing Financial Toxicity With Patients and Health Systems

July 23rd 2021, 1:30pm

Article

Speakers at the Advanced Topics for Oncology Pharmacy Professionals Summit discussed financial toxicity in health care, how it particularly impacts patients with cancer, and how to address the issue with patients and the health system.

CMS Seeks Changes to Radiation Oncology Model; ASTRO Responds

July 20th 2021, 9:04pm

Article

Due to unprecedented disruption and missed screenings during the pandemic, efforts to implement a 5-year performance period under the Radiation Oncology Model were extended twice.

Dr Todd Schlesinger: Surgical Decisions for Skin Cancer Are Multimodal

July 16th 2021, 6:00pm

Video

The characteristics of the tumor and the presence of surgical fatigue can help determine patients’ candidacy for skin cancer surgery, explained Todd Schlesinger, MD, FAAD, director, Dermatology and Laser Center of Charleston and Clinical Research Center of the Carolinas.

ASCO, COA Release Updated Standards for Oncology Medical Home

July 13th 2021, 6:00pm

Article

The new standards come as community oncology practices await word on the future of the oncology care model, which will expire in 2022.

Obesity, Disparities, and Treatment Advancements Shape US Cancer Trends

July 8th 2021, 10:00am

Article

New data underscore how obesity, racial disparities and recent treatment advancements have impacted cancer mortality and incidence rates.

Next-Generation Oncology APMs Need More Planning to Succeed

July 1st 2021, 3:00pm

Article

Originally set to expire on June 30, 2021, the Oncology Care Model was extended for an additional year in light of the COVID-19 pandemic.

Weidner et al, Appendices

June 21st 2021, 10:00pm

Article

Appendices to: Observations Regarding the Average Sales Price Reimbursement Methodology

Real-World Evidence Is Key to Accelerating Oncology Approvals

June 21st 2021, 7:19pm

Article

A Social Worker Leads ACCC, and Her Timing Is Perfect

June 19th 2021, 9:04pm

Article

Phase 2 Data for Tisagenlecleucel, Tafasitamab Show Objective Responses in More Than Half of Patients

June 19th 2021, 3:22pm

Article

Both sets of data were unveiled at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, which was held earlier this month in a virtual format.